Herbal formula shows promise for Crohn's in tiny early trial
NCT ID NCT03992469
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 34 times
Summary
This early study tests an oral herbal formula called E-B-FAHF-2 in 7 adults with mild-to-moderate Crohn's disease. The main goal is to see if it is safe and tolerable, and to explore whether it can help control inflammation. Researchers also check how the formula affects immune cells and gut tissue. This is a Phase 1 trial, so it is very early and not designed to prove the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.